ONQUALITY PHARMACEUTICALS CHINA LTD has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Canada, China and United States. Its main competitors in its focus markets pharmaceuticals are GRAS ESCARDO JORDI, ROTTAPHARM BV and ARJIL BIOTECH HOLDING COMPANY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Liu Chao | 11 |
#2 | Luo Jie | 11 |
#3 | Wu Zhaoyu | 11 |
#4 | Chen Leying | 11 |
#5 | Zhang Shiyi | 11 |
#6 | Yang Linan | 7 |
#7 | Sun Songxuan | 3 |
#8 | Gong Zhehui | 3 |
#9 | Xing Rui | 3 |
#10 | Zhao Xin | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021073535A1 | Method for preventing or treating diseases associated with administration of vegfr and/or vegf inhibitor | |
CA3097067A1 | Method for preventing or treating side effects of cancer therapy | |
CN111601617A | Method for preventing or treating diseases related to EGFR inhibition |